A recent survey made by the World Health Organization and the U.S. Centers for Disease Control and Prevention, nearly 1 in 30 human cases of tuberculosis (TB) is now more resistant to both primary nad secondary antibiotic treatments. The survey reports that the prevalence of "multiple-drug resistant" TB strains, which can survive the first two antibiotics typically used rose from 29 to 39 percent between 2000 and 2004. The use of streptomycin and other antibiotics made the disease highly treatable but due to misuse of these drugs has allowed resistant strains to flourish. Pharmaceutical companies and nonprofit initiatives speeds up their R&D efforts in response to this rising of TB resistance. Still, the key is to ensure that patients complete the full course of treatment to prevent such TB resistance.
|Number of pages||1|
|Specialist publication||World Watch|
|Publication status||Published - Jul 1 2006|
ASJC Scopus subject areas
- Geography, Planning and Development